Archives

This protocol outlines the methods for a prospective cohort study in long-term care facilities (LTCFs) to evaluate the effectiveness of COVID-19 vaccines in preventing laboratory-confirmed SARS-CoV-2 symptomatic infection in LTCF residents.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 August 2022 and includes updates on COVID-19, monkeypox, West Nile virus infection, swine influenza, Vibrio growth, poliovirus and poliomyelitis.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 August 2022 and includes updates on West Nile virus infection, COVID-19, monkeypox, measles, Crimean-Congo haemorrhagic fever, Langya henipavirus, dengue, mass gatherings at the Birmingham 2022 commonwealth games, Vibrio growth, swine influenza and polio.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 July-6 August and includes updates on West Nile virus infection, monkeypox, COVID-19, cholera, diphteria, anthrax, Vibrio growth, Marburg virus disease, mass gatherings at the Birmingham 2022 Commonwealth games, MERS-CoV, and Poliovirus.

The objective of this document is to present the available methods for detection and characterisation of circulating SARS-CoV-2 variants.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24 -30 July and includes updates on COVID-19, monkeypox, West Nile virus, increase in hepatitis of unknown aetiology in children, mass gatherings in the Birmingham 2022 Commonwealth games, Vibrio growth, Marburg disease, Chikungunya, dengue, and wild poliovirus.

Technical report containing the outcomes of a consultation to identify knowledge and research gaps related to the COVID-19 public health response.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17 – 23 July and includes updates on COVID-19, monkeypox, West Nile virus, Marburg virus disease, polio, cholera, Vibrio growth in the Baltic Sea and mass gathering for Hajj.

This document outlines operational considerations to support the continuity of national surveillance systems and public health laboratories for epidemiological and virological surveillance for influenza, SARS-CoV-2, and potentially other respiratory viruses in the 2022/2023 winter season and beyond.

This document offers an overview of the available scientific and epidemiological evidence and provides public health considerations to support decisions on the implementation of additional booster doses of COVID-19 vaccine.